Barings Corporate Investors (MCI) Income Statement Analysis

See more : Burger Fuel Group Limited (BFG.NZ) Income Statement Analysis – Financial Results

Complete financial analysis of Barings Corporate Investors (MCI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Barings Corporate Investors, a leading company in the Asset Management industry within the Financial Services sector.

You may be interested

Captiva Verde Wellness Corp. (CPIVF) Income Statement Analysis – Financial Results
IRRC Corporation (7325.T) Income Statement Analysis – Financial Results
InterPrivate IV InfraTech Partners Inc. (IPVIW) Income Statement Analysis – Financial Results
Yash Chemex Limited (YASHCHEM.BO) Income Statement Analysis – Financial Results
Enad Global 7 AB (publ) (ENADF) Income Statement Analysis – Financial Results

Barings Corporate Investors (MCI)

Industry: Asset Management

Sector: Financial Services

Website: https://www.babsoncapital.com/Strategies/Trusts/MCI/Default.aspx

About Barings Corporate Investors

Babson Capital Corporate Investors trust is a closed ended fixed income mutual fund launched and managed by Barings LLC. It invests in fixed income markets of the United States. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in a portfolio of privately placed, below-investment grade, long term corporate debt obligations. The fund also invests in marketable investment grade debt securities, other marketable debt securities, and marketable common stocks. It was formerly known as Babson Capital Corporate Investors. Babson Capital Corporate Investors trust was formed in 1971 and is domiciled in the United States.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Revenue	41.19M	16.21M	54.45M	16.22M	39.95M	10.99M	44.54M	28.18M	26.80M	30.20M	28.88M	30.25M
Cost of Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Gross Profit	41.19M	16.21M	54.45M	16.22M	39.95M	10.99M	44.54M	28.18M	26.80M	30.20M	28.88M	30.25M
Gross Profit Ratio	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	1.34M	1.18M	1.05M	889.01K	937.22K	1.40M	964.49K	4.43M	4.79M	4.63M	4.43M	4.16M
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	1.34M	1.18M	1.05M	889.01K	937.22K	1.40M	964.49K	4.43M	4.79M	4.63M	4.43M	4.16M
Other Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Expenses	1.34M	1.18M	1.05M	889.01K	937.22K	1.40M	964.49K	641.25K	7.93M	4.14M	4.88M	11.15M
Cost & Expenses	5.62M	1.18M	1.05M	889.01K	937.22K	1.40M	964.49K	641.25K	7.93M	4.14M	4.88M	11.15M
Interest Income	40.63M	28.08M	24.33M	28.70M	27.60M	29.45M	27.96M	1.58M	1.58M	1.58M	1.58M	1.58M
Interest Expense	2.08M	1.71M	1.07M	1.06M	1.06M	1.06M	1.52M	0.00	0.00	0.00	0.00	0.00
Depreciation & Amortization	-46.47K	-23.32M	-20.54M	-25.45M	-23.64M	-25.27M	-26.77M	-23.76M	-22.01M	-25.57M	-24.45M	-26.09M
EBITDA	0.00	0.00	67.19M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	13.73M
EBITDA Ratio	0.00%	103.28%	98.07%	94.52%	97.65%	96.88%	101.24%	12.36%	-17.63%	23.80%	26.74%	45.38%
Operating Income	35.57M	16.74M	53.39M	15.33M	39.01M	10.65M	45.10M	23.76M	22.01M	25.57M	24.45M	26.09M
Operating Income Ratio	86.36%	103.28%	98.07%	94.52%	97.65%	96.88%	101.24%	84.29%	82.13%	84.68%	84.68%	86.25%
Total Other Income/Expenses	2.09M	-7.91M	406.60K	-10.11M	15.37M	-15.68M	16.81M	3.48M	-4.72M	7.19M	7.72M	13.73M
Income Before Tax	37.67M	15.03M	53.39M	15.33M	39.01M	9.59M	43.58M	27.24M	17.28M	32.76M	32.18M	39.82M
Income Before Tax Ratio	91.45%	92.72%	98.07%	94.52%	97.65%	87.24%	97.83%	96.65%	64.49%	108.48%	111.41%	131.63%
Income Tax Expense	706.22K	766.22K	585.25K	15.33M	39.01M	-161.14K	26.77M	3.48M	-4.72M	7.19M	7.72M	2.12M
Net Income	36.96M	14.26M	52.81M	15.33M	39.01M	9.59M	43.58M	27.24M	17.28M	32.76M	32.18M	37.70M
Net Income Ratio	89.73%	88.00%	96.99%	94.52%	97.65%	87.24%	97.83%	96.65%	64.49%	108.48%	111.41%	124.63%
EPS	1.82	0.71	2.60	0.76	1.93	0.48	2.19	1.38	0.88	1.68	1.66	1.96
EPS Diluted	1.82	0.71	2.60	0.76	1.93	0.48	2.19	1.38	0.88	1.68	1.66	1.96
Weighted Avg Shares Out	20.26M	20.09M	20.26M	20.18M	20.21M	19.97M	19.90M	19.79M	19.66M	19.53M	19.39M	19.24M
Weighted Avg Shares Out (Dil)	20.26M	20.09M	20.31M	20.18M	20.21M	19.97M	19.90M	19.79M	19.66M	19.53M	19.39M	19.24M

Squarepoint Ops LLC Sells 12,946 Shares of Arcosa Inc (NYSE:ACA)

July 2, 2020thelincolnianonline.com

Squarepoint Ops LLC reduced its stake in Arcosa Inc (NYSE:ACA) by 50.0% during the first quarter, HoldingsChannel.com reports. The fund owned 12,967 shares of the company’s stock after selling 12,946 shares during the quarter. Squarepoint Ops LLC’s holdings in Arcosa...

Abbott Laboratories (NYSE:ABT) Shares Bought by Axa

July 2, 2020thelincolnianonline.com

Axa boosted its stake in shares of Abbott Laboratories (NYSE:ABT) by 11.6% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 526,473 shares of the healthcare product maker’s stock after purchasing an additional...

Axa Increases Stock Position in Netflix, Inc. (NASDAQ:NFLX)

July 2, 2020thelincolnianonline.com

Axa grew its holdings in Netflix, Inc. (NASDAQ:NFLX) by 21.3% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 127,555 shares of the Internet television network’s stock after buying an additional 22,374 shares...